Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Net Cash Flow (2016 - 2026)

Sunshine Biopharma filings provide 14 years of Net Cash Flow readings, the most recent being -$941715.0 for Q4 2025.

  • On a quarterly basis, Net Cash Flow rose 50.04% to -$941715.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$1.4 million, a 74.49% increase, with the full-year FY2025 number at -$1.4 million, up 74.49% from a year prior.
  • Net Cash Flow hit -$941715.0 in Q4 2025 for Sunshine Biopharma, down from -$770559.0 in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $28.5 million in Q2 2022 to a low of -$19.0 million in Q4 2022.
  • Median Net Cash Flow over the past 5 years was -$418886.5 (2021), compared with a mean of $384287.0.
  • Biggest five-year swings in Net Cash Flow: surged 41959.55% in 2022 and later plummeted 25270.25% in 2024.
  • Sunshine Biopharma's Net Cash Flow stood at -$335777.0 in 2021, then tumbled by 5547.28% to -$19.0 million in 2022, then skyrocketed by 84.23% to -$3.0 million in 2023, then soared by 36.95% to -$1.9 million in 2024, then surged by 50.04% to -$941715.0 in 2025.
  • The last three reported values for Net Cash Flow were -$941715.0 (Q4 2025), -$770559.0 (Q3 2025), and $1.8 million (Q2 2025) per Business Quant data.